United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Apr 27, 2026 · Filed Apr 28, 2026

On Apr 27, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$568.83 for US$5.69M under a trading plan, leaving 18,876 shares. Filed Apr 28, 2026 (Form 4).

Sold
10,000 shares
Price
US$568.83 average (US$565.85 to US$571.92)
Value
US$5.69M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 27, 2026Common StockOption exercise10,000US$135.4228,876Direct
Apr 27, 2026Common StockSale1,716US$565.8527,160Direct
Apr 27, 2026Common StockSale1,449US$566.7325,711Direct
Apr 27, 2026Common StockSale919US$567.8124,792Direct
Apr 27, 2026Common StockSale1,107US$569.0123,685Direct
Apr 27, 2026Common StockSale2,405US$570.0521,280Direct
Apr 27, 2026Common StockSale1,755US$571.1019,525Direct
Apr 27, 2026Common StockSale649US$571.9218,876Direct

Source

View original at SEC

Related